Literature DB >> 11079057

Performance of screening mammography in organized programs in Canada in 1996. The Database Management Subcommittee to the National Committee for the Canadian Breast Cancer Screening Initiative.

D Paquette1, J Snider, F Bouchard, I Olivotto, H Bryant, K Decker, G Doyle.   

Abstract

BACKGROUND: The results of randomized trials show that breast cancer screening by mammography reduces breast cancer mortality by up to 40% in women aged 50-69 years. Because of these results, by 1998, 22 countries, including Canada, had established population-based organized screening programs. This paper presents the results of screening mammography in 1996 for 7 provincially organized breast cancer screening programs in Canada.
METHODS: Analyses of interim performance indicators for screening mammography have been calculated from data submitted to the Canadian Breast Cancer Screening database. The data set consisted of data from 7 provincial programs and was limited to mammographic screens for women aged 50-69 years (n = 203,303). Screening outcomes and performance indicators were calculated for abnormalities detected by screening mammography only.
RESULTS: The abnormal recall rate was 9.5% for first screens and 4.6% for subsequent screens, and the cancer detection rate per 1000 women screened was 6.9 for first screens and 3.8 for subsequent screens. The positive predictive value (i.e., the proportion of women who tested positive by mammography who were found to have breast cancer on screen-initiated diagnostic work-up) increased from 7.2% at the first screen to 8.2% at subsequent screens. Estimated participation rates within organized programs varied from 10.6% to 54.2%, depending on the province.
INTERPRETATION: For 1996, organized breast cancer screening programs met or exceeded many of the interim measures used in international programs. It is possible to translate the benefits of breast cancer screening by mammography, as demonstrated in randomized trials, into population-based community programs. Screening mammography through organized programs should increase to allow more comprehensive monitoring in Canada.

Entities:  

Mesh:

Year:  2000        PMID: 11079057      PMCID: PMC80245     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  20 in total

1.  Breast cancer screening in 21 countries: delivery of services, notification of results and outcomes ascertainment.

Authors:  R Ballard-Barbash; C Klabunde; E Paci; M Broeders; E A Coleman; J Fracheboud; F Bouchard; G Rennert; S Shapiro
Journal:  Eur J Cancer Prev       Date:  1999-10       Impact factor: 2.497

2.  Efficacy of screening mammography. A meta-analysis.

Authors:  K Kerlikowske; D Grady; S M Rubin; C Sandrock; V L Ernster
Journal:  JAMA       Date:  1995-01-11       Impact factor: 56.272

3.  Potential contribution of screening to cancer mortality reduction.

Authors:  M Hakama
Journal:  Cancer Detect Prev       Date:  1993

4.  Ten- to fourteen-year effect of screening on breast cancer mortality.

Authors:  S Shapiro; W Venet; P Strax; L Venet; R Roeser
Journal:  J Natl Cancer Inst       Date:  1982-08       Impact factor: 13.506

5.  Quality assurance and cancer detection rates in a provincial screening mammography program. Work in progress.

Authors:  H E Bryant; J E Desautels; W R Castor; N Horeczko; F Jackson; Z Mah
Journal:  Radiology       Date:  1993-09       Impact factor: 11.105

6.  Population-based mammography screening in Swedish clinical practice: prevalence and incidence screening in Uppsala County.

Authors:  E L Thurfjell; J A Lindgren
Journal:  Radiology       Date:  1994-11       Impact factor: 11.105

7.  Update of the Swedish two-county program of mammographic screening for breast cancer.

Authors:  L Tabàr; G Fagerberg; S W Duffy; N E Day; A Gad; O Gröntoft
Journal:  Radiol Clin North Am       Date:  1992-01       Impact factor: 2.303

8.  Nova Scotia Breast Screening Program experience: use of needle core biopsy in the diagnosis of screening-detected abnormalities.

Authors:  J S Caines; K Chantziantoniou; B A Wright; G P Konok; S E Iles; A Bodurtha; I Zayid; C Daniels
Journal:  Radiology       Date:  1996-01       Impact factor: 11.105

9.  Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.

Authors:  L Tabár; C J Fagerberg; A Gad; L Baldetorp; L H Holmberg; O Gröntoft; U Ljungquist; B Lundström; J C Månson; G Eklund
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

10.  Breast cancer screening programmes: the development of a monitoring and evaluation system.

Authors:  N E Day; D R Williams; K T Khaw
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

View more
  14 in total

1.  Detection of breast cancer. Clinical breast examination is not an acceptable alternative to mammography.

Authors:  C J de Wolf
Journal:  BMJ       Date:  2001-03-31

2.  Organized breast cancer screening programs in Canada.

Authors:  A B Miller
Journal:  CMAJ       Date:  2000-10-31       Impact factor: 8.262

3.  Improving the time to diagnosis after an abnormal screening mammogram.

Authors:  I A Olivotto; M J Borugian; L Kan; S R Harris; E J Rousseau; S E Thorne; J A Vestrup; C J Wright; A J Coldman; T G Hislop
Journal:  Can J Public Health       Date:  2001 Sep-Oct

4.  Delivering equitable care: comparing preventive services in Manitoba.

Authors:  Sumit Gupta; Leslie L Roos; Randy Walld; Dawn Traverse; Matthew Dahl
Journal:  Am J Public Health       Date:  2003-12       Impact factor: 9.308

5.  Cancer preventive screening: a cross-border comparison of United States and Canadian Chinese women.

Authors:  Shin-Ping Tu; Sara L Jackson; Yutaka Yasui; Michéle Deschamps; T Gregory Hislop; Vicky M Taylor
Journal:  Prev Med       Date:  2005-07       Impact factor: 4.018

6.  Adherence to cancer screening guidelines across Canadian provinces: an observational study.

Authors:  Erin C Strumpf; Zhijin Chai; Srikanth Kadiyala
Journal:  BMC Cancer       Date:  2010-06-18       Impact factor: 4.430

7.  Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces.

Authors:  I A Olivotto; C Bancej; V Goel; J Snider; R G McAuley; B Irvine; L Kan; D Mirsky; M J Sabine; R McGilly; J S Caines
Journal:  CMAJ       Date:  2001-08-07       Impact factor: 8.262

8.  Mammography FastTrack: an intervention to facilitate reminders for breast cancer screening across a heterogeneous multi-clinic primary care network.

Authors:  William T Lester; Jeffrey M Ashburner; Richard W Grant; Henry C Chueh; Michael J Barry; Steven J Atlas
Journal:  J Am Med Inform Assoc       Date:  2008-12-11       Impact factor: 4.497

9.  Improving work-up of the abnormal mammogram through organized assessment: results from the ontario breast screening program.

Authors:  May Lynn Quan; Rene S Shumak; Vicky Majpruz; Claire M D Holloway; Frances P O'Malley; Anna M Chiarelli
Journal:  J Oncol Pract       Date:  2012-02-14       Impact factor: 3.840

10.  Dedicated screening mammography for diagnosis of small breast cancer.

Authors:  Boris Kirshtein; Pavel Crystal; Michael Koretz; Selwyn Strano
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.